Appuhn V, S.; Siebert, S.; Myti, D.; Wrede, C.; Solaligue, D. E. S.; Perez-Bravo, D.; Brandenberger, C.; Schipke, J.; Morty, R. E.; Grothausmann, R.et al.; Muehlfeld, C.: Capillary Changes Precede Disordered Alveolarization in a Mouse Model of Bronchopulmonary Dysplasia. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 65 (1), pp. 81 - 91 (2021)
Rath, P.; Nardiello, C.; Solaligue, D. E. S.; Agius, R.; Mizikova, I.; Huehn, S.; Mayer, K.; Vadasz, I.; Herold, S.; Runkel, F.et al.; Seeger, W.; Morty, R. E.: Caffeine administration modulates TGF-beta signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia. PEDIATRIC RESEARCH 81 (5), pp. 795 - 805 (2017)
Solaligue, D. E. S.; Rodriguez-Castillo, J. A.; Ahlbrecht, K.; Morty, R. E.: Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY 313 (6), pp. L1101 - L1153 (2017)
Tiono, J.; Solaligue, D. E. S.; Mizikova, I.; Morty, R.; Seeger, W.: Impact Of Mouse Strain On Arrested Alveolarization In Response To Hyperoxia Exposure As Neonates. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 195 (2017)
Solaligue, D. E. S.; Silva, D.; Seeger, W.; Morty, R. E.: A Role For Microrna-29c In Arrested Alveolarization Associated With Experimental Bronchopulmonary Dysplasia. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 193 (2016)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).